Apollo Hospitals Enterprise Ltd vs Suraksha Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 03, 2026

Key Highlights

The Latest Trading Price of Apollo Hospitals Enterprise Ltd is ₹ 7316 as of 02 Apr 15:30 . The P/E Ratio of Apollo Hospitals Enterprise Ltd changed from 277.5 on March 2021 to 65.9 on March 2025 . This represents a CAGR of -24.99% over 5 yearsThe P/E Ratio of Suraksha Diagnostic Ltd changed from 42.2 on March 2025 to 42.2 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Apollo Hospitals Enterprise Ltd changed from ₹ 41739 crore on March 2021 to ₹ 95218 crore on March 2025 . This represents a CAGR of 17.93% over 5 yearsThe Market Cap of Suraksha Diagnostic Ltd changed from ₹ 1342 crore on March 2025 to ₹ 1342 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Apollo Hospitals Enterprise Ltd for the Dec '25 is ₹ 6545 crore as compare to the Sep '25 revenue of ₹ 6364 crore. This represent the growth of 2.84% The revenue of Suraksha Diagnostic Ltd for the Dec '25 is ₹ 78.31 crore as compare to the Sep '25 revenue of ₹ 79.58 crore. This represent the decline of -1.6% The ebitda of Apollo Hospitals Enterprise Ltd for the Dec '25 is ₹ 1013 crore as compare to the Sep '25 ebitda of ₹ 1002 crore. This represent the growth of 1.17% The ebitda of Suraksha Diagnostic Ltd for the Dec '25 is ₹ 23.78 crore as compare to the Sep '25 ebitda of ₹ 24.97 crore. This represent the decline of -4.77% The net profit of Apollo Hospitals Enterprise Ltd changed from ₹ 315.5 crore to ₹ 516.3 crore over 7 quarters. This represents a CAGR of 32.50% The net profit of Suraksha Diagnostic Ltd changed from ₹ 7.67 crore to ₹ 7.24 crore over 7 quarters. This represents a CAGR of -3.24% The Dividend Payout of Apollo Hospitals Enterprise Ltd changed from 41.09 % on March 2021 to 14.04 % on March 2025 . This represents a CAGR of -19.33% over 5 yearsThe Dividend Payout of Suraksha Diagnostic Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Limited (AHEL) is a leading private sector healthcare provider in Asia.
It has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics.
AHEL's Hospitals are situated in Chennai, Hyderabad, Delhi, Ahmedabad, Pune, Chenganur, Coimbatore, Jaipur, Madurai, Anantpur, Nellore, Kurnool, Bhopal, Ranchi, Bilaspur and Bacheli.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis and providing / selling high quality pharma and wellness products through a network of pharmacies.
The principal activities of the Company include operation of multidisciplinary private hospitals, clinics and pharmacies. Apollo Hospitals Enterprise Limited was incorporated as a Public Limited Company on December 5, 1979, a comprehensive 250-bed hospital with an emphasis on speciality and super specialties in over fifty departments at Chennai.

About Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata.
Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India.
In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors.

FAQs for the comparison of Apollo Hospitals Enterprise Ltd and Suraksha Diagnostic Ltd

Which company has a larger market capitalization, Apollo Hospitals Enterprise Ltd or Suraksha Diagnostic Ltd?

Market cap of Apollo Hospitals Enterprise Ltd is 105,197 Cr while Market cap of Suraksha Diagnostic Ltd is 1,273 Cr

What are the key factors driving the stock performance of Apollo Hospitals Enterprise Ltd and Suraksha Diagnostic Ltd?

The stock performance of Apollo Hospitals Enterprise Ltd and Suraksha Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Apollo Hospitals Enterprise Ltd and Suraksha Diagnostic Ltd?

As of April 3, 2026, the Apollo Hospitals Enterprise Ltd stock price is INR ₹7316.35. On the other hand, Suraksha Diagnostic Ltd stock price is INR ₹244.5.

How do dividend payouts of Apollo Hospitals Enterprise Ltd and Suraksha Diagnostic Ltd compare?

To compare the dividend payouts of Apollo Hospitals Enterprise Ltd and Suraksha Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.